Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.4 USD | +22.88% | +30.56% | +13.12% |
04-17 | IGM Biosciences, Sanofi Narrow Partnership to Focus on Potential Immunology and Inflamation Targets | MT |
04-17 | IGM Biosciences, Inc. Announces Refocusing of Sanofi Collaboration | CI |
Sales 2024 * | 3.04M 4.15M | Sales 2025 * | 12.25M 16.73M | Capitalization | 554M 757M |
---|---|---|---|---|---|
Net income 2024 * | -200M -273M | Net income 2025 * | -222M -303M | EV / Sales 2024 * | 127 x |
Net cash position 2024 * | 168M 229M | Net cash position 2025 * | 170M 232M | EV / Sales 2025 * | 31.4 x |
P/E ratio 2024 * |
-2.89
x | P/E ratio 2025 * |
-3.24
x | Employees | 224 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 36.53% |
Latest transcript on IGM Biosciences, Inc.
1 day | +22.88% | ||
1 week | +30.56% | ||
Current month | -2.59% | ||
1 month | +1.40% | ||
3 months | -11.57% | ||
6 months | +128.16% | ||
Current year | +13.12% |
Managers | Title | Age | Since |
---|---|---|---|
Fred Schwarzer
CEO | Chief Executive Officer | 72 | 03-01-31 |
Misbah Tahir
DFI | Director of Finance/CFO | 49 | 18-12-31 |
T. S. Harigopal
COO | Chief Operating Officer | - | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Felix Baker
BRD | Director/Board Member | 55 | 21-01-25 |
M. Wilsey
BRD | Director/Board Member | 71 | 19-01-30 |
Fred Schwarzer
CEO | Chief Executive Officer | 72 | 03-01-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.03% | 0 M€ | 0.00% | - | |
0.01% | 2 M€ | -.--% | ||
0.00% | 9 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 9.4 | +22.88% | 468,943 |
24-04-25 | 7.65 | -3.89% | 546,460 |
24-04-24 | 7.96 | +3.38% | 693,446 |
24-04-23 | 7.7 | +14.07% | 413,520 |
24-04-22 | 6.75 | -6.25% | 238,720 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.12% | 554M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- IGMS Stock